DEF 14AThe Ballot
Travere Therapeutics, Inc. files DEF 14A
Filed Apr 6, 2026 · 2mo ago · Accession 0001438533-26-000027
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Travere Therapeutics, Inc.
- Ticker
- TVTX
- CIK
- 1438533
- Form type
- DEF 14A
- Filing date
- Apr 6, 2026
- Report date
- May 19, 2026
- Document
- tvtx-20260404.htm
- Size
- 3.9 MB